Latest news
Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 09:14:37 GMTAscletis Announces Initiation of Global Phase III for Oral Small Molecule GLP-1, ASC30 and Positive Preclinical Data for Its First-in-Class Oral Small Molecule GLP-1/GIP/Amylin Fixed-Dose Combination - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 10:55:00 GMT